Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01232881
Recruitment Status : Terminated (funding terminated)
First Posted : November 2, 2010
Last Update Posted : April 28, 2011
United States Department of Defense
Indiana University School of Medicine
Emory University
Information provided by:
Hoosier Cancer Research Network

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : November 2010
  Actual Study Completion Date : November 2010